tiprankstipranks
Advertisement
Advertisement

GRCE Stock Latest News

Grace Therapeutics Raises Capital to Advance GTx-104 Program
Company AnnouncementsGrace Therapeutics Raises Capital to Advance GTx-104 Program
15d ago
8K
GRCE
Grace Therapeutics to issue 4.762M shares at $2.10 in private placement
PremiumThe Fly
Grace Therapeutics to issue 4.762M shares at $2.10 in private placement
16d ago
GRCE
Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104
PremiumThe Fly
Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104
16d ago
GRCE
Grace Therapeutics advances dual-source manufacturing for GTx-104
PremiumCompany Announcements
Grace Therapeutics advances dual-source manufacturing for GTx-104
24d ago
8K
GRCE
Grace Therapeutics receives Type A meeting minutes from FDA
PremiumThe Fly
Grace Therapeutics receives Type A meeting minutes from FDA
24d ago
GRCE
Midday Fly By: Trump says Apple working with Intel to design chips
PremiumThe FlyMidday Fly By: Trump says Apple working with Intel to design chips
2M ago
KR
ACN
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
Premium
Company Announcements
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
2M ago
8K
GRCE
Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year
Premium
The Fly
Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year
2M ago
GRCE
Grace Therapeutics VP of Clinical Operations Departs Role
PremiumCompany Announcements
Grace Therapeutics VP of Clinical Operations Departs Role
3M ago
8K
GRCE
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
PS
KDK
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
BUD
KDK
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
PremiumCompany Announcements
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
4M ago
8K
GRCE
Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum
PremiumThe FlyGrace Therapeutics price target lowered to $4 from $11 at Craig-Hallum
4M ago
GRCE
Grace Therapeutics price target lowered to $8 from $12 at TD Cowen
Premium
The Fly
Grace Therapeutics price target lowered to $8 from $12 at TD Cowen
4M ago
GRCE
Grace Therapeutics: Buy Rating Maintained as Addressable CMC Setback Delays but Does Not Derail GTx‑104 Value Thesis
Premium
Ratings
Grace Therapeutics: Buy Rating Maintained as Addressable CMC Setback Delays but Does Not Derail GTx‑104 Value Thesis
4M ago
GRCE
Grace Therapeutics Receives FDA Complete Response for GTx-104
PremiumCompany Announcements
Grace Therapeutics Receives FDA Complete Response for GTx-104
4M ago
8K
GRCE
Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
PremiumThe Fly
Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
4M ago
GRCE
Grace Therapeutics, Inc trading resumes
PremiumThe Fly
Grace Therapeutics, Inc trading resumes
4M ago
GRCE
Grace Therapeutics issued Complete Response Letter from FDA
PremiumThe Fly
Grace Therapeutics issued Complete Response Letter from FDA
4M ago
GRCE
Grace Therapeutics, Inc trading halted, news pending
PremiumThe FlyGrace Therapeutics, Inc trading halted, news pending
4M ago
GRCE
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
Premium
The Fly
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
6M ago
GRCE
Ten new option listings and two option delistings on January 22nd
Premium
The Fly
Ten new option listings and two option delistings on January 22nd
7M ago
AVR
INR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >